Leonard S. Schleifer

2012

In 2012, Leonard S. Schleifer earned a total compensation of $30M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 184% increase compared to previous year.

Compensation breakdown

Bonus$2,300,000
Option Awards$26,630,306
Salary$1,000,000
Other$116,791
Total$30,047,097

Schleifer received $26.6M in option awards, accounting for 88.63% of the total pay in 2012.

Schleifer also received $2.3M in bonus, $1M in salary and $116.8K in other compensation.

Rankings

In 2012, Leonard S. Schleifer's compensation ranked 37th out of 11,285 executive pay records tracked by us. In other words, Schleifer earned more than 99.7% of all executives tracked by us in 2012.

ClassificationRankingPercentile
All
37
out of 11,285
100th
Manufacturing
Division
16
out of 4,153
100th
Chemicals And Allied Products
Major group
3
out of 1,141
100th
Drugs
Industry group
3
out of 879
100th
Pharmaceutical Preparations
Industry
2
out of 663
100th
Source: SEC filing on April 21, 2015.

Schleifer's colleagues

We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2012.

2012

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2012

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2012

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

2012

Robert Terifay

Regeneron Pharmaceuticals

Senior Vice President, Commercial

News

In-depth

You may also like